{"schema_version":"secwatch.filing_event.v1","accession":"0001326110-25-000084","form_type":"8-K","ticker":"IBRX","cik":"0001326110","company_name":"ImmunityBio, Inc.","filed_at":"2025-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.936810+00:00","generated_at":"2026-05-19T01:01:48.695296+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"ImmunityBio stockholders approve 2025 Equity Incentive Plan, re-elect directors","bullets":["2025 Equity Incentive Plan approved; reserves 46,088,027 new shares plus up to 32,359,674 from expired/forfeited 2015 Plan awards.","All eight director nominees re-elected at June 18, 2025 annual meeting; 89% of shares represented.","Deloitte & Touche ratified as independent auditor for fiscal 2025 with 99.5% votes in favor.","Plan replaces 2015 Plan; no further awards under prior plan, but existing grants continue."],"urls":{"canonical":"https://secwatch.observer/filing/0001326110-25-000084","json":"https://secwatch.observer/filing/0001326110-25-000084.json","markdown":"https://secwatch.observer/filing/0001326110-25-000084.md","text":"https://secwatch.observer/filing/0001326110-25-000084.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000084/0001326110-25-000084-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326110/000132611025000084/ibrx-20250618.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T01:01:48.695296+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}